Mai Capital Management Twist Bioscience Corp Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Twist Bioscience Corp stock. As of the latest transaction made, Mai Capital Management holds 18 shares of TWST stock, worth $743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$743% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
270Shares Held
67.2MCall Options Held
118KPut Options Held
40.2K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$243 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$240 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$231 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$224 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$148 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.33B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...